chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Never ending headache; Interchange of vaccine products; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 15Nov2022 as dose 4 (booster), single (Lot number: G10446) at the age of 65 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: modrena covid-19 vaccine (DOSE 3 (BOOSTER), SINGLE, Batch/Lot: 032H21A, Location of injection: Left arm), administration date: 11Jan2022, for COVID-19 immunisation; Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 immunisation. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious) with onset 15Nov2022, outcome "not recovered"; HEADACHE (non-serious) with onset 20Nov2022, outcome "not recovered", described as "Never ending headache". The event "never ending headache" required physician office visit. Therapeutic measures were taken as a result of headache.  Additional Information: Patient got vaccine at Doctor's office/urgent care. Patient had treatment with mucous relief ER 600, azithromycin, diclofenac. Patient did not have COVID prior vaccination nor he was tested COVID post vaccination.
She developed a high fever lasting several days.  It broke twice during the length of about 6 days.  She was listless, lethargic and unresponsive for 3 days and started being able to look at us with intent on the fourth.  She had stopped making cooing sounds, smiling, reaching for us/things. When she did look at us, she had Nystagmus symptoms. She was unable to track anything or look at anything without having her eyes jerking back and forth for close to a month. She wasn't back on the WHO developmental track until she was 10 months old. Luckily, I exclusively breastfed and only did the one vaccine at the time.  Otherwise, she may have a permanent injury that would potentially impede her ability to read and eventually drive a car.
This is a spontaneous report from a non-contactable consumer. A 37-year-old female not pregnant patient  A 37-year-old female patient not pregnant, received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), unknown route of administration, administered in arm left on 10Feb2021 10:45 (Batch/Lot number EL3247) (age at vaccination 37 year) as single dose for COVID-19 immunization. Patient received the first dose of BNT162B2 (Batch/Lot number EL3247) on 20Jan2021, unknown route of administration, administered in left arm. Medical history included was not reported.  The patient's concomitant medications were not reported.  On 10Feb2021 11:00 PM,  patient experienced Pain at site of injection, mild muscles aches, mild tiredness. No treatment received. Outcome of events was recovering. No follow-up attempts are needed. Information about Lot/batch number cannot be obtained.
Chills, shaking, cold extremities, then mild fever, aches, headache unable to sleep all night until 6 am. Following day unable to get out of bed, still aching, fatigue and headache. Third day still tired feeling a little better.
Went into a seizure; Completely unconscious; Extreme arm pain; Arm swelling; Woke up freezing; Did not feel well; Body aches; Felt tiredness; Felt like fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of SEIZURE (Went into a seizure) and LOSS OF CONSCIOUSNESS (Completely unconscious) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced SEIZURE (Went into a seizure) (seriousness criteria hospitalization and medically significant), LOSS OF CONSCIOUSNESS (Completely unconscious) (seriousness criteria hospitalization and medically significant), PAIN IN EXTREMITY (Extreme arm pain), PERIPHERAL SWELLING (Arm swelling), FEELING COLD (Woke up freezing), MALAISE (Did not feel well), PAIN (Body aches), FATIGUE (Felt tiredness), PYREXIA (Felt like fever) and CHILLS (Chills). At the time of the report, SEIZURE (Went into a seizure), LOSS OF CONSCIOUSNESS (Completely unconscious), PAIN IN EXTREMITY (Extreme arm pain), PERIPHERAL SWELLING (Arm swelling), FEELING COLD (Woke up freezing), MALAISE (Did not feel well), PAIN (Body aches), FATIGUE (Felt tiredness), PYREXIA (Felt like fever) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Apr-2021, Body temperature: 99.5 (High) 99.5.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included paracetamol.  Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
swelling of the arm; neurologic issues; balance issues; red rash; Information has been received from a lawyer regarding a case in litigation and referring to a female patient (pt) of unknown age. Information about the pt's concurrent conditions, medical history and concomitant medications was not reported. On an unknown date, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date, reported as after receiving zoster vaccine live (ZOSTAVAX), the pt suffered red rash, swelling of the arm, neurologic issues and balance issues. As a result of these symptoms, the pt was seen and treated by medical providers and at the time of report was still under their care. As a direct and proximate result of the defective zoster vaccine live (ZOSTAVAX) vaccine, the pt's symptoms had resulted in physical limitations not present prior to using the suspect product. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of the pt's condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence of the vaccine live (ZOSTAVAX), the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was not recovered. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).  The events of red rash, swelling of the arm, neurologic issues and balance issues were considered to be disabling.
Patient given 0.1ml dose as recommended at the time of administration. it was discovered later that there was a pediatric formula available and to no longer use the purple capped at a lower dose for pediatrics.  no adverse reaction noted, no other treatment required,
Information has been received from a 25 year old female with allergies (gets allergy shots every five years) who on 19-JAN-2009 was vaccinated with the second dose of GARDASIL (LOT # was not provided) and fainted right after. The patient indicated she was fine after the first dose of GARDASIL. Subsequently the patient recovered from fainted and had no other symptoms. It was unknown that the patient sought medical attention. No further information is available.
4:30 went out to dinner drank 4 beers, ate a few french fries and bites of burger then said he wasn't feeling well. 5:30 pm that day nauseated and pale, dicphoratic, stumbling. 1am 2/10/06 till in the middle of the night, disoriented fell and broke rib, nausea, vomiting.  Went to ER. These events reported by daughter.
Client states pain @ site after injection noted redness swelling on 1/25/10 but noticed migration of erythema and induration down arm this am. (Was told by physician to take TYLENOL). Denies itching, fever and only minimal pain @ present. Area of redness and swelling noted to start approximately 1 1/2 in below injection site. Area warm to touch. Approx 5" x 3" size of swelling/erythema.
Patient given 2nd dose of vaccine 21 days after receiving the first dose. Upon follow-up with patient she experienced no adverse events from the vaccine.
fever; shivering; This case was reported by a consumer via call center representative and described the occurrence of fever in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th October 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 17th October 2019, 1 days after receiving Shingrix, the patient experienced fever and shivering. On an unknown date, the outcome of the fever and shivering were not recovered/not resolved.   It was unknown if the reporter considered the fever and shivering to be related to Shingrix.  Additional details were provided as follows: On the day of reporting, in the morning the patient experienced shivering and fever. Her fever was 100.4 degrees F. The reporter consented to follow up.
pt has severe onset of diarrhea x 5 for 12hrs;no prior sx;personal physician called;
Pt had redness and swelling at the site that reportedly decreased in size since 2/26 (date of vaccination).  Pt also reported pain in joints which subsided in a few days.
C/o weakness. I felt dizzy for 1-2 days after flu shot. He din't act himself and was tired, staggered when walking. Lasted for 1-2 day.
She reports that the shot and may have been administered higher than usual and felt the injection distributed into her upper arm. She tells me that she had not felt that type of reaction previously. She reports the pain worsened the next day and has not improved since and has intermittently worsened.
fairly significant muscle pain; headache; stomachache; slight fever; This case was reported by a consumer and described the occurrence of muscle pain in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, unknown after receiving Shingrix, the patient experienced muscle pain, headache, stomach pain and fever. On an unknown date, the outcome of the muscle pain, headache, stomach pain and fever were recovered/resolved.   It was unknown if the reporter considered the muscle pain, headache, stomach pain and fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient was vaccinated with Shingrix. The patient experienced fairly significant muscle pain, headache, stomachache, and a slight fever after vaccination. The events were lasted for 1 day. The symptoms were not serious. The physician was aware of the reactions from the 1st dose. Patient gave permission to contact their physician, and provided the contact information. For tolerance with 2nd dose refer case US2020AMR240731. The reporter did not consent to follow up. Not all information was available.
Menstruation came 2 weeks early (2 weeks right after my cycle ended); heavier flow; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. On an unknown date, after receiving the first dose, the patient had menstruation came 2 weeks early (2 weeks right after cycle ended) and heavier flow. Patient stated that this had never happened before. The clinical outcome of the event menstruation irregular and heavier flow were unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Swelling, itching for 4 days following injection  Some relief with OTC Benadryl  10 days following injection site is raised, red and itching again
After administration she feel numbness on lips and then started tingling in her finger and hand. After hour I check with her she was tired.
Patient without adverse symptoms. Patient tolerated vaccine well and departed after 15minute observation time.  Instructed to submit VAERS due to patient reporting receiving Pfizer vaccine on 24Aug2021 on screening form during mass vaccination event. During post vaccine administration documentation patient found to have received Moderna not Pfizer on 24Aug2021. Patient received Pfizer on 17Sep21 instead of receiving Moderna.  Patient aware informed of findings.
Extreme tiredness at first. Then headache, joint and muscle pain. Some nausea. Slight fever (99.2) Took tylenol and advil and slept it off. Missed one day of work.
Her arm was painful, swollen and red, and size of the area was like a cell phone.
Information has been received from a certified medical assistant concerning a 22 year old female with shrimp allergy who on 13-SEP-2007 was vaccinated with the first dose of Gardasil (lot #658488/0930U).  Concomitant therapy included NUVARING and ALLEGRA.  On 14-SEP-2007 the following morning, the patient experienced an "allergic reaction".  The certified medical assistant characterized the reaction as "extreme dizziness", a facial "rash" which spread to her chest and back, swelling of her eyelids, "nausea", "fever" and "muscle aches".  The patient sought unspecified medical attention and was treated with BENADRYL. Subsequently on an unspecified date, the patient recovered from extreme dizziness, facial rash which spread to chest and back, swelling of her eyelids, nausea, fever and muscle aches.  Additional information has been requested.
On four occasions in the two years since the vaccine, pt has developed severe burning, pruritus and PHN type symptoms in the shoulders, especially in the one the vaccine was given in.  Previous episodes have resolved spontaneously, but current episode has lasted over a month.
9/2/10 Localized redness to vaccine injection site (R) upper arm noted with edema. Approximately 35-40 cm. Slight redness & edema noted to (L) upper arm. IZs giv 8/31/10. Mother brought child into clinic 9/2. States redness & edema better. At this time mother states NOV other s/s or fever. Child has full ROM. - Mother to apply cool or wm compresses & f/u with MD if redness edema continues or if any concerns.
After receiving the vaccine, the next day in the afternoon I started getting extreme joint pain in my left hand and fingers. It progressively went to the other side of my body throughout the day. I couldn't move my fingers or hands without being in tears. I couldn't do anything with my hands. That pain lasted for about 2 days. I called my doctor and they told me to do labs. I haven't experienced pain to that extent in years. The pain had went away by Tuesday. I have no current symptoms. Today I am following up with a rheumatologist in regards to my lab results.
children were prescribed unknown antibiotics and then developed thrush.; children ended up in unknown emergency rooms with high fevers; This spontaneous report was received from a registered nurse and refers to a child patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies, and drug reactions or allergies were not provided.  On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection (strength, dose, frequency, lot #, and expiration date not reported) for prophylaxis.  On an unknown date, also reported as "after receiving measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II)", the child ended up in an unknown emergency room with high fevers (pyrexia). Subsequently, the patient was prescribed unknown antibiotics (antimicrobial (unspecified)) (strength, dose, frequency, lot #, and expiration date not reported) for an unknown indication. On an unspecified date, the patient developed thrush (candida infection). It was noted that the reporter inquired about the availability of measles virus vaccine, live (Enders-Edmonston) (ATTENUVAX) and mumps virus vaccine live (MUMPSVAX). The action taken with antibiotics (unspecified) regarding the events was not reported. The outcome of the events was unknown. No further information provided.  The causal relationship between pyrexia, candida infection and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was not reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2002USA011146: US-009507513-2002USA008445:
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 15-AUG-2014 the patient was vaccinated intramuscularly with a dose of GARDASIL (once, 0.5ml, dose in series was unspecified, lot# was one of the following: J009243, expiration date 23-APR-2016 or J010668, expiration date 29-APR-2016) that was improperly stored at -0.5C for 1.5 hours. No adverse effects were reported. No PQC (product quality complaint) was involved. Additional information has been requested.
ON 4/28 felt intense pain in legs and blurry eyes, slowly went away after taking advil, came back at night, on thursday 4/29 pain continued and had shortness of breath decided to go to urgent care made appt for 4/30 813AM, at Urgent Care  symptoms pointed to blood clots was told to go to local imaging company to get sonogram, sonogram showed blood clots in leg told to go to emergency room, went to Hospital and was admitted, confirmed blood clots and put on blood thinner neprin IV, released 5/2 at 1PM, at home now on blood thinner pills 10mg Eliquis
approx 2in red area around vax site;it became red & hot (sore) for 1 1/2-2wk;
10/18/09 Primarily fever and headache (101) Continued ill with highest 102.  She is improving this am.  10/27/09 F/U with mom - fully recovered - twin brother with similar s/s
Received 2 Hibs. Child did not show any signs or symptoms adverse reaction from receiving extra dose of hib and infant was monitored for 48 hours.
Diagnosed with Type 1 Diabetes Mellitus 10 days after receiving 3rd dose of GARDASIL vaccine made by Merck.  8/25/09 PCP records rec'd. WCC with no concerns 6/3/08-healthy.  HPV#1 given. Returned 12/30/08 with c/o fatigue x several weeks, eating and drinking more than usual and rapid wt loss.  Urine (+) for ketones at home. Assessment:  Diabetes mellitus.  Labs:  Urinalysis (+) for protein 30, trace blood, large ketones (160). glucose 1000.  BS 358.   9/3/09 Hospital records received DOS 12/30/08 to 1/1/09. Assessment: Diabetes mellitus new onset, Diabetic ketoacidosis. Presented with recent weight loss, increased thirst, increased urination, increased hunger. Generalized weakness, fatigue, headache, fever. Episode of vomiting. Constipation. Decreased muscle bulk.
patient called up to pharmacy at request of medical office.  said he had to have abscess drained at site of injection, 2 weeks after injection given at pharmacy
11/27/2021- Presented to ER with weakness, vomiting, fall 3 days prior. Vitals WNL. Found to be Covid positive with AKI/Hyponatremia and Hypokalemia/Dehydration. eFGR 28. Na 125, K 3.2 - 2L fluid administered. Came in on room air and was started on Monoclonal antibodies but since then developed O2 dependence. Started on Decadron.  11/28 - closely monitoring GI bleed. Hemoglobin 8.6 - baseline 10. 11/29 - AKI improving. d/c fluids. Covid improved. Decadron continued, weaned down from 2L O2. Doing fine on room air. Hemoglobin dropped to 4.3-Transfused 3U PRBC 12/1 - Mid chest to lung base bilateral rhonchus noted. Started on Ceftriaxone and Doxy. Added 2L O2 NC to remain above 93% saturation.  12/4/2022-  breathing and lungs improve Will continue on Rocephin, Doxy, and weaning down O2. Saturation in high 90s. Hb is stable in 10 range.  12/6 - Rocephin and Decadron complete. No longer requiring O2. Will complete Doxy. Significant clinical improvement.  Discharged to home
Information has been received from a physician concerning a female who was vaccinated with a dose of Rotateq. The physician reported that the patient subsequently developed a circular, 4 mL ulcer on her soft palate which had a raised red border with a clear center. It was unknown if medical attention was sought. At the time of this report, the outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
Swelling, redness, induration to left anteriolateral thigh; no systemic fever, no pallor, developed within 24 hours of vaccine administration.  Resolved within 72 hours.  Benadryl, Duricef, cool compresses.
I received my 5th dose on 09/20/2022. My COVID-19 symptoms started on 12/17/2022 around 08:00PM.  I had a runny nose, sneezing, headache, sore throat, fever, chills chest congestions, and diarrhea.  It was very mild. I went to the Urgent Care on 12/19/2022 at 11:00AM. I tested positive on 12/19/2022 at 09:00AM using a home COVID-19 test. I also went to  a local health clinic on 12/19/2022 for a PCR test at 10:30AM. I received the results on 12/20/2022  which was positive. At the Urgent Care they prescribed me with Paxlovid for 5 days.  I am recovering  from the COVID-19 infection  as of today 12/21/2022.
Got flu shot, had a little cold, but not too bad; Initial information was received on 27-Oct-2020 regarding an unsolicited valid non-serious case from a social media via consumer or non-health care professional.  This case is linked to cases 2020SA305170, 2020SA305230 and 2020SA305527.  This case involves a male patient of unknown age who had a little cold, but not too bad (nasopharyngitis), after he received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received an unknown dose of INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date (unknown latency), the patient had a little cold, but not too bad (nasopharyngitis), following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the patient was recovering from the event.  There will be no information available on lot number.